A modern approach to classify missense mutations in cardiac channelopathy genes

Circulation: Cardiovascular Genetics

Volumn 5, Issue 5, 2012, Pages 487-489

  Abriel, Hugues ^a   Zaklyazminskaya, Elena V ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

Bioinfomatics genes; Brugada syndrome; Editorials; Ion channels; Long QT syndrome

Indexed keywords

ION CHANNEL; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNQ1; VOLTAGE GATED POTASSIUM CHANNEL;

BIOINFORMATICS; BRUGADA SYNDROME; CARDIAC CHANNELOPATHY; EDITORIAL; ETHNICITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEART ARRHYTHMIA; HUMAN; KCNH2 GENE; KCNQ1 GENE; LONG QT SYNDROME; MISSENSE MUTATION; NONHUMAN; PATHOGENICITY; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL;

HUMANS; LONG QT SYNDROME; ROMANO-WARD SYNDROME;

EID: 84868627726     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.112.964809     Document Type: Editorial

References (20)

1. Ashcroft FM. From molecule to malady. Nature. 2006;440:440-447.
2. Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell. 2001;104:569-580. (Pubitemid 32201951)
3. Napolitano C, Bloise R, Monteforte N, Priori SG. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catechol-aminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. Circulation. 2012;125:2027-2034.
4. Crotti L, Marcou CA, Tester DJ, Castelletti S, Giudicessi JR, Torchio M, et al. Spectrum and prevalence of mutations involving BrS1-through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing. J Am Coll Cardiol. In Press.
5. Zaklyazminskaya EV, Abriel H. Prevalence of significant genetic variants in congenital long QT syndrome is largely underestimated. Front Pharmacol. 2012;3:72.
6. Ackerman MJ, Tester DJ, Jones GS, Will ML, Burrow CR, Curran ME. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc. 2003;78:1479-1487. (Pubitemid 37475631)
7. Kapa S, Tester DJ, Salisbury BA, Harris-Kerr C, Pungliya MS, Alders M, et al. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation. 2009;120:1752-1760.
8. Anonymous. NHLBI Exome sequencing project. 2012. Accessed September 26, 2012. evs.gs.washington.edu/EVS
9. Bell J, Bodmer D, Sistermans E, Ramsden SC. Practice guidelines for the Interpretation and Reporting of Unclassifed Variants (UVs) in Clinical Molecular Genetics. 2007. Accessed September 26, 2012. www.cmgs.org/BPGs/ pdfs%20current%20bpgs/UV%20GUIDELINES%20ratifed.pdf.
10. Ho CY, MacRae CA. Defning the pathogenicity of DNA sequence variation. Circ Cardiovasc Genet. 2009;2:95-97.
11. Mohler PJ, Rivolta I, Napolitano C, Le Maillet G, Lambert S, Priori SG, et al. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci U S A. 2004;101:17533-17538. (Pubitemid 39657438)
12. Watanabe H, Yang T, Stroud DM, Lowe JS, Harris L, Atack TC, et al. Striking in vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Circulation. 2011;124:1001-1011.
13. Crotti L, Spazzolini C, Schwartz PJ, Shimizu W, Denjoy I, Schulze-Bahr E, et al. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation. 2007;116:2366-2375. (Pubitemid 350145071)
14. Giudicessi JR, Kapplinger JD, Tester DJ, Alders M, Salisbury BA, Wilde AA, et al. Phylogenetic and physicochemical analyses enhance the clas-sification of rare non-synonymous single nucleotide variants in type 1 and 2 long QT syndrome. Circ Cardiovasc Genet. xxx. 2012.
15. Jons C, Moss AJ, Lopes CM, McNitt S, Zareba W, Goldenberg I, et al. Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome. J Cardiovasc Electrophysiol. 2009;20:859-865.
16. Faa' V, Coiana A, Incani F, Costantino L, Cao A, Rosatelli MC. A synonymous mutation in the CFTR gene causes aberrant splicing in an Italian patient affected by a mild form of cystic fibrosis. J Mol Diagn. 2010;12:380-383.
17. Chao HK, Hsiao KJ, Su TS. A silent mutation induces exon skipping in the phenylalanine hydroxylase gene in phenylketonuria. Hum Genet. 2001;108:14-19.
18. Moss AJ, Goldenberg I. Importance of knowing the genotype and the spe-cific mutation when managing patients with long QT syndrome. Circ Arrhythm Electrophysiol. 2008;1:213-226; discussion 226.
19. Wilde AA, Brugada R. Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac sodium channel. Circ Res. 2011;108:884-897.
20. Bellcross CA, Page PZ, Meaney-Delman D. Direct-to-consumer personal genome testing and cancer risk prediction. Cancer J. 2012;18:293-302.